There is a specific moment when a medical term stops being a word and becomes a weight. It doesn't happen in the doctor's office. It happens later — maybe three days later, maybe three months — when the syllables finally sink past your intellect and settle somewhere below the sternum, where all the real things live.
For me, that word was CADASIL.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. A name so long and precise and clinical that it almost functions as camouflage — you can stare at it for a long time before what it actually means becomes clear. And what it means is this: my mother's blood vessels are slowly narrowing. Small ones, deep in her brain. The walls thickening like old pipes in an old house. And there is a coin-flip's chance that mine are doing the same thing, right now, quietly, without my knowing.
I haven't called that coin yet.
The Name of the Thing
CADASIL was first named in 1993 by French researchers Marie-Germaine Bousser and Elisabeth Tournier-Lasserve. Three years later, the gene responsible — NOTCH3, on chromosome 19 — was identified by Anne Joutel and her colleagues. It was a meaningful discovery. Not because it offered a cure — there still is none — but because naming a thing is how medicine begins to approach it. And for decades before that naming, the families living with this disease had no name at all. Just early strokes. Just dementia that arrived too young. Just the slow unraveling of a person who had seemed, until recently, entirely themselves.
Here is what it is, plainly: CADASIL is the most common hereditary stroke disorder in adults. A mutation in the NOTCH3 gene causes the walls of small blood vessels in the brain to thicken and stiffen — a condition called arteriopathy. These vessels lose their ability to carry blood efficiently. The brain, which runs on roughly twenty percent of the body's oxygen on a moment-to-moment basis, begins to starve in increments so small they are often invisible for years.
The earliest symptoms can appear in the late twenties. Migraines with aura — those strange, ancient headaches that arrive with visual disturbances, halos, and blind spots at the edge of perception — are often the first signal. The clinical literature puts the mean age of first migraine onset at around 28. The first TIA or stroke tends to follow in the early forties. Then the erosion continues, slowly, for decades. Cognition slows. Executive function falters. Mood shifts — depression, apathy, a flattening of emotional range — become part of the picture.
By the time most patients reach 65, they have some degree of cognitive impairment or dementia. Around two-thirds will develop dementia at some point. The average life expectancy with CADASIL is approximately 61 years. In the final stages, 80 percent of patients are completely dependent on caregivers. This is not a disease that announces itself dramatically. It is a disease of slow erosion — patient, quiet, and without mercy.
It is also, by genetic law, exactly 50 percent inheritable. If one of your parents carries the NOTCH3 mutation, each of their children receives one flip of the coin. Heads, you're clear. Tails, you carry it. The disease does not discriminate by character, by circumstance, or by how badly you want to be the exception.
The House I Recognized
I was somewhere in the middle of Mike Flanagan's The Fall of the House of Usher when I paused the screen.
Not because of a jump scare — Flanagan is too good a filmmaker for those. I paused because Roderick Usher, the crumbling patriarch played by Bruce Greenwood, sat across from a federal prosecutor and said, plainly, that he had CADASIL. Vascular dementia. Inherited from his mother. And I sat in my living room in Wyoming, in the dark, and felt something cold move through me that I can only describe as recognition.
Flanagan built the 2023 Netflix miniseries as a modern adaptation of multiple Edgar Allan Poe works — most prominently Poe's 1839 short story of the same name. In Poe's original, Roderick Usher suffers from a nervous illness, an acute hypersensitivity to existence itself, while the ancestral house around him cracks and sinks into the earth. The house is the family. The family is the disease. The architecture deteriorates in perfect correspondence to the man inside it.
In Flanagan's hands, the metaphor becomes explicit, and medical. The disease is CADASIL. The horror doesn't diminish when it gets a clinical name — if anything, it deepens. Because now the monster isn't haunting the house. The monster is a gene. A misfolded protein accumulating in the smooth muscle cells of the brain's smallest vessels. You cannot board up a gene's windows. You cannot walk away from its address.
The scariest horror is the one inscribed in the architecture of the family itself — that you did not choose, cannot renegotiate, and can only, in the end, witness.
Roderick's mother, Eliza, also had CADASIL in the series. She refused medical care. The disease passed from her to her son — clean as arithmetic. Autosomal dominant. One copy of the altered gene is sufficient. Flanagan stages this inheritance not as tragedy but as inevitability, which is the more honest register. Tragedy implies it could have gone differently. This kind of inheritance doesn't offer that comfort.
What Flanagan captured — without ever stating it in clinical language — is what living alongside this disease actually feels like. You watch a man who built an empire slowly lose the resolution of his own thoughts. The ghosts he sees may be hallucinations from a deteriorating brain, or they may be manifestations of guilt made visible. Flanagan refuses to resolve that ambiguity, which is exactly right. Because the person watching a loved one with CADASIL lives inside that same fog. You cannot always tell whether what you're observing is the disease or the person. Whether the flatness is clinical apathy — a documented CADASIL symptom — or ordinary fatigue. Whether the word that vanished mid-sentence was a neurological event or an ordinary human moment.
I watched all eight episodes. I watched a man decay from the inside while maintaining, for a time, the external architecture of authority and composure. I thought about my mother through every one of them.
What I Watch
There is a particular grief that has no clean name in English — the grief of watching a living person change into someone you are still trying to recognize.
Psychologists use the term anticipatory grief: the sorrow felt for a loss that hasn't fully arrived yet. It is the emotional condition of every family member living alongside a progressive neurological disease. You are grieving and not grieving simultaneously. The person is here. And in some sense you can't fully articulate — they are also, incrementally, leaving.
With CADASIL, the timeline is slow enough that you can almost convince yourself you're overreacting. A missed word here. A moment of confusion there. The slight flatness behind the eyes you noticed months ago and chose to file away as nothing. But the mind catalogs these things whether you direct it to or not. Pattern recognition is not something you switch off simply because the pattern is one you'd rather not see.
What's harder to talk about is what sustained witnessing does to your internal architecture. It doesn't just add tasks to a list. It rewrites something more fundamental. You become a person who checks in with a different frequency. Who preserves certain conversations — for the neurologist, for the next family discussion, for the record you're keeping that you never formally decided to start keeping. You become, in small and incremental ways you don't immediately recognize, a different kind of careful.
And beneath all of it, if you are being honest — which this requires — is something that sits uncomfortably close to guilt for watching at all. You don't want to be the person who is cataloging decline. But you are. And that discomfort, the weight of being the witness, is part of what no one talks about and everyone living this knows.